Medicare Enrolled
Dr. Harshad Amin, M.D.
Hematology & Oncology · Plantation, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Amin
Dr. Harshad Amin is a hematology & oncology specialist in Plantation, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Amin performed 90,314 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Amin received a total of $189,606 from 86 pharmaceutical and/or device companies across 2011 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years of NPI registration
▲ Top 8% volume in FL
$189,606 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 118635 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗90,314
Medicare services
Top 8% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
34,501 | $1 | $5 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
28,300 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 9,200 | $43 | $146 |
| Denosumab injection (Prolia/Xgeva) | 8,460 | $18 | $70 |
| Iron infusion (Monoferric) | 3,600 | $16 | $77 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,399 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,219 | $8 | $35 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
664 | $68 | $148 |
| Anti-nausea injection (Aloxi/palonosetron) | 620 | $1 | $122 |
| Anti-nausea injection (ondansetron/Zofran) | 352 | $0 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $102 | $224 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
306 | $11 | $93 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
254 | $23 | $152 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
205 | $102 | $686 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
165 | $100 | $233 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
114 | $50 | $304 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
108 | $1 | $7 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
96 | $145 | $410 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
93 | $12 | $105 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
90 | $52 | $334 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
83 | $132 | $343 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
75 | $22 | $156 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
54 | $66 | $157 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $43 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
42.9% high complexity
54.2% medium
2.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$189,606
Total received (2018-2024)
Avg $27,087/year across 7 years
Top 5% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
86
Companies
2,011
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,102
2023
$9,734
2022
$19,030
2021
$28,729
2020
$27,809
2019
$62,903
2018
$35,299
Payments by company (2024)
Bayer Healthcare Pharmaceuticals Inc.
$1,467
PFIZER INC.
$815
AstraZeneca Pharmaceuticals LP
$465
Merck Sharp & Dohme LLC
$329
Novartis Pharmaceuticals Corporation
$261
E.R. Squibb & Sons, L.L.C.
$250
Celgene Corporation
$241
Eisai Inc.
$208
Daiichi Sankyo Inc.
$186
Genentech USA, Inc.
$178
Takeda Pharmaceuticals U.S.A., Inc.
$173
Incyte Corporation
$173
GENZYME CORPORATION
$160
TAIHO ONCOLOGY, INC.
$109
Rigel Pharmaceuticals, Inc.
$87
ARRAY BIOPHARMA INC
$79
Janssen Biotech, Inc.
$68
Lilly USA, LLC
$68
ABBVIE INC.
$66
Pharmacosmos Therapeutics Inc.
$63
Karyopharm Therapeutics Inc.
$56
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
PUMA BIOTECHNOLOGY, INC.
$54
SERVIER PHARMACEUTICALS LLC
$54
Exelixis Inc.
$52
Sumitomo Pharma America, Inc.
$45
BeiGene USA, Inc.
$42
RECORDATI_RARE_DISEASES_INC.
$41
Mirati Therapeutics, Inc.
$39
Ipsen Biopharmaceuticals, Inc
$30
Amneal Pharmaceuticals LLC
$28
Adaptive Biotechnologies Corporation
$26
Deciphera Pharmaceuticals Inc.
$26
Kyowa Kirin, Inc.
$26
Regeneron Healthcare Solutions, Inc.
$23
Alexion Pharmaceuticals, Inc.
$22
Tolmar, Inc.
$19
JAZZ PHARMACEUTICALS INC.
$17
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$92,280
Celgene Corporation
$15,968
Global Blood Therapeutics, Inc.
$9,545
Acceleron Pharma, Inc.
$7,430
Bayer HealthCare Pharmaceuticals Inc.
$6,121
JAZZ PHARMACEUTICALS INC.
$4,253
Keryx Biopharmaceuticals, Inc.
$4,243
Exelixis Inc.
$3,934
GlaxoSmithKline, LLC.
$3,424
Eli Lilly Export S.A. Puerto Rico Branch
$3,415
Takeda Pharmaceuticals U.S.A., Inc.
$3,272
Janssen Biotech, Inc.
$3,210
E.R. Squibb & Sons, L.L.C.
$2,799
AstraZeneca Pharmaceuticals LP
$2,611
Ipsen Biopharmaceuticals, Inc
$2,537
PFIZER INC.
$2,396
Novartis Pharmaceuticals Corporation
$2,059
Genentech USA, Inc.
$2,000
Dova Pharmaceuticals
$1,896
Bayer Healthcare Pharmaceuticals Inc.
$1,547
Rigel Pharmaceuticals, Inc.
$1,490
GENZYME CORPORATION
$1,325
Seagen Inc.
$1,033
Incyte Corporation
$873
Merck Sharp & Dohme LLC
$859
Eisai Inc.
$719
Amgen Inc.
$709
Astellas Pharma US Inc
$632
Merck Sharp & Dohme Corporation
$557
Alexion Pharmaceuticals, Inc.
$457
Daiichi Sankyo Inc.
$351
Foundation Medicine, Inc.
$260
EISAI INC.
$254
Deciphera Pharmaceuticals Inc.
$247
AVEO Pharmaceuticals, Inc.
$239
ARRAY BIOPHARMA INC
$236
Seattle Genetics, Inc.
$231
Pharmacyclics LLC, An AbbVie Company
$218
PUMA BIOTECHNOLOGY, INC.
$212
Karyopharm Therapeutics Inc.
$206
Novocure GmbH
$200
AbbVie Inc.
$182
Puma Biotechnology, Inc.
$180
Boehringer Ingelheim Pharmaceuticals, Inc.
$178
ABBVIE INC.
$178
Athenex Pharmaceutical Division, LLC
$175
TAIHO ONCOLOGY, INC.
$172
Mirati Therapeutics, Inc.
$168
Pharmacosmos Therapeutics Inc.
$165
Regeneron Healthcare Solutions, Inc.
$161
Adaptive Biotechnologies Corporation
$141
EMD Serono, Inc.
$135
Sirtex Medical Inc
$117
BeiGene USA, Inc.
$109
AbbVie, Inc.
$98
Myovant Sciences Inc.
$96
Janssen Pharmaceuticals, Inc
$81
Kyowa Kirin, Inc.
$81
Taiho Oncology, Inc.
$77
Agios Pharmaceuticals, Inc.
$72
TG Therapeutics, Inc.
$64
Teva Pharmaceuticals USA, Inc.
$64
Amneal Pharmaceuticals LLC
$54
SERVIER PHARMACEUTICALS LLC
$54
Sobi, Inc
$47
Sumitomo Pharma America, Inc.
$45
MorphoSys, US Inc.
$41
RECORDATI_RARE_DISEASES_INC.
$41
MEDIVATION FIELD SOLUTIONS LLC
$39
Epizyme, Inc.,
$37
Myriad Genetic Laboratories, Inc.
$30
Alnylam Pharmaceuticals Inc.
$27
Sun Pharmaceutical Industries Inc.
$25
Sandoz Inc.
$24
ADC Therapeutics America, Inc.
$21
Pharmacyclics LLC, an AbbVie Company
$20
TG THERAPEUTICS, INC.
$20
Tolmar, Inc.
$19
G1 Therapeutics, Inc.
$18
Advanced Accelerator Applications
$18
Jazz Pharmaceuticals Inc.
$17
Integra LifeSciences Corporation
$16
SOBI, INC
$15
Secura Bio, Inc.
$14
Clovis Oncology, Inc.
$13
Gilead Sciences, Inc.
$12
Top 3 companies account for 62.1% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · Abraxane · Alecensa · Aliqopa · Aranesp · Auryxia · Avastin · BAVENCIO · BENDEKA · BILAYER WOUND MATRIX (BWM) · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · DAURISMO · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Erleada · FOTIVDA · FOUNDATIONFOCUS · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Fedratinib · GAZYVA · GILOTRIF · GIVLAARI · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Luspatercept · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · Reblozyl · Revlimid · Rezlidhia · Rituxan Hycela · Rozlytrek · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · YONSA · ZARXIO · ZEJULA · ZEPZELCA · ZIEXTENZO · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
116
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
WESTSIDE REGIONAL MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Amin is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Amin experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Amin performed 34,501 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $189,606 from 86 companies across 2,011 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other hematology & oncology specialists in Plantation?
Dr. Amin's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Plantation
Browse hematology & oncology specialists in Plantation ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Global Blood Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Global Blood Therapeutics, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology